AP NEWS

Osteogenesis Imperfecta - Pipeline Review, H2 2018 - ResearchAndMarkets.com

September 28, 2018

DUBLIN--(BUSINESS WIRE)--Sep 28, 2018--The “Osteogenesis Imperfecta - Pipeline Review, H2 2018” drug pipelines has been added to ResearchAndMarkets.com’s offering.

Osteogenesis Imperfecta - Pipeline Review, H2 2018, provides comprehensive information on the therapeutics under development for Osteogenesis Imperfecta (Genetic Disorders), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Osteogenesis Imperfecta (Genetic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Osteogenesis Imperfecta and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities/Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I, Preclinical and Discovery stages are 1, 1, 1, 2 and 1 respectively.

Osteogenesis Imperfecta (Genetic Disorders) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Companies Featured

Amgen Inc. Bone Therapeutics SA Genzyme Corp. Mereo Biopharma Group plc Mesentech Inc. SOM Biotech SL

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/z3s7cf/osteogenesis?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180928005368/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Musculoskeletal Disorders Drugs

KEYWORD:

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 09/28/2018 11:00 AM/DISC: 09/28/2018 11:01 AM

http://www.businesswire.com/news/home/20180928005368/en

AP RADIO
Update hourly